Table 5 Hemolysis effect in terms of CC50 values (concentration causing 50% hemolysis) by THTT derivatives at varying concentrations.

From: Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations

Treatment groups

CC50 µM

95% confidence interval

BG

375.68

264.64–406.24

PG

401.65

342.39–460.84

T9

104.61

85.63–123.61

T24

104.51

86.74–122.27

T25

89.73

76.35–103.19

Triton-x

78.19

77.92–78.45

  1. The CC50 values indicate the cytotoxicity of each compound towards red blood cells, providing insight into their potential hemolytic effects.